Abstract
Abstract
Case fatality rate (CFR) and doubling time are important characteristics of any epidemic. For coronavirus disease 2019 (COVID-19), wide variations in the CFR and doubling time have been noted among various countries. Early in the epidemic, CFR calculations involving all patients as denominator do not account for the hospitalised patients who are ill and will die in the future. Hence, we calculated cumulative CFR (cCFR) using only patients whose final clinical outcomes were known at a certain time point. We also estimated the daily average doubling time. Calculating CFR using this method leads to temporal stability in the fatality rates, the cCFR stabilises at different values for different countries. The possible reasons for this are an improved outcome rate by the end of the epidemic and a wider testing strategy. The United States, France, Turkey and China had high cCFR at the start due to low outcome rate. By 22 April, Germany, China and South Korea had a low cCFR. China and South Korea controlled the epidemic and achieved high doubling times. The doubling time in Russia did not cross 10 days during the study period.
Publisher
Cambridge University Press (CUP)
Subject
Infectious Diseases,Epidemiology
Reference14 articles.
1. Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence;Banerjee;bioRxiv,2020
2. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens
3. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
4. 4. COVID-19 Map Johns Hopkins Coronavirus Resource Center [Internet]. 2020 [cited 2020 April 22]. Available at https://coronavirus.jhu.edu/map.html.
5. Severe Acute Respiratory Syndrome: Temporal Stability and Geographic Variation in Case-Fatality Rates and Doubling Times
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献